BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 7494299)

  • 41. Promoter complex in the central part of the mouse mammary tumor virus long terminal repeat.
    Rouault F; Nejad Asl SB; Rungaldier S; Fuchs E; Salmons B; Günzburg WH
    J Virol; 2007 Nov; 81(22):12572-81. PubMed ID: 17686873
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of transcripts derived from promoter III of the acetyl-CoA carboxylase-alpha gene in mammary gland is associated with recruitment of SREBP-1 to a region of the proximal promoter defined by a DNase I hypersensitive site.
    Barber MC; Vallance AJ; Kennedy HT; Travers MT
    Biochem J; 2003 Oct; 375(Pt 2):489-501. PubMed ID: 12871210
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of a MMTV/mdr3 fusion transcript from a cryptic viral promoter is stimulated by mdr-derived sequences located in intron I.
    Lepage P; Underhill DA; Gros P
    Virology; 1995 Jul; 210(2):244-53. PubMed ID: 7618265
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lactogenic hormones and extracellular matrix regulate expression of IGF-1 linked to MMTV-LTR in mammary epithelial cells.
    Romagnolo D; Akers RM; Wong EA; Boyle PL; McFadden TB; Byatt JC; Turner JD
    Mol Cell Endocrinol; 1993 Oct; 96(1-2):147-57. PubMed ID: 8276130
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of a novel mammary cell line-specific enhancer element in the long terminal repeat of mouse mammary tumor virus, which interacts with its hormone-responsive element.
    Yanagawa S; Tanaka H; Ishimoto A
    J Virol; 1991 Jan; 65(1):526-31. PubMed ID: 1845907
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nuclear factor 1 is required for both hormone-dependent chromatin remodeling and transcriptional activation of the mouse mammary tumor virus promoter.
    Hebbar PB; Archer TK
    Mol Cell Biol; 2003 Feb; 23(3):887-98. PubMed ID: 12529394
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Specific deactivation of the mouse mammary tumor virus long terminal repeat promoter upon continuous hormone treatment.
    Boronat S; Richard-Foy H; Piña B
    J Biol Chem; 1997 Aug; 272(35):21803-10. PubMed ID: 9268310
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endogenous superantigen expression controlled by a novel promoter in the MMTV long terminal repeat.
    Günzburg WH; Heinemann F; Wintersperger S; Miethke T; Wagner H; Erfle V; Salmons B
    Nature; 1993 Jul; 364(6433):154-8. PubMed ID: 8391646
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ubiquitous transcription factor OTF-1 mediates induction of the MMTV promoter through synergistic interaction with hormone receptors.
    Brüggemeier U; Kalff M; Franke S; Scheidereit C; Beato M
    Cell; 1991 Feb; 64(3):565-72. PubMed ID: 1846780
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Purified glucocorticoid receptor-hormone complex from rat liver cytosol binds specifically to cloned mouse mammary tumor virus long terminal repeats in vitro.
    Govindan MV; Spiess E; Majors J
    Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5157-61. PubMed ID: 6291027
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The interaction of a c-Jun/Fos related protein factor with the U3 sequences of the mouse mammary tumor virus LTR.
    Siddique HR; Sarkar NH
    Biochem Biophys Res Commun; 1990 Oct; 172(1):348-56. PubMed ID: 2171522
    [TBL] [Abstract][Full Text] [Related]  

  • 52. cis-acting regulatory elements in the bovine immunodeficiency virus long terminal repeat.
    Fong SE; Pallansch LA; Mikovits JA; Lackman-Smith CS; Ruscetti FW; Gonda MA
    Virology; 1995 Jun; 209(2):604-14. PubMed ID: 7778292
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phorbol ester-inducible T-cell-specific expression of variant mouse mammary tumor virus long terminal repeats.
    Theunissen HJ; Paardekooper M; Maduro LJ; Michalides RJ; Nusse R
    J Virol; 1989 Aug; 63(8):3466-71. PubMed ID: 2545916
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MMTV-associated transcription factor binding sites increase nm23-H1 metastasis suppressor gene expression in human breast carcinoma cell lines.
    Ouatas T; Clare SE; Hartsough MT; De La Rosa A; Steeg PS
    Clin Exp Metastasis; 2002; 19(1):35-42. PubMed ID: 11918081
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cloning and kidney cell-specific activity of the promoter of the murine renal Na-K-C1 cotransporter gene.
    Igarashi P; Whyte DA; Li K; Nagami GT
    J Biol Chem; 1996 Apr; 271(16):9666-74. PubMed ID: 8621642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A small region of the mouse mammary tumor virus long terminal repeat confers glucocorticoid hormone regulation on a linked heterologous gene.
    Majors J; Varmus HE
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):5866-70. PubMed ID: 6310597
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potentiation of glucocorticoid receptor-mediated gene expression by heat and chemical shock.
    Sanchez ER; Hu JL; Zhong S; Shen P; Greene MJ; Housley PR
    Mol Endocrinol; 1994 Apr; 8(4):408-21. PubMed ID: 8052262
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulation of avian leukosis virus long terminal repeat-enhanced transcription by C/EBP-Rel interactions.
    Bowers WJ; Baglia LA; Ruddel A
    J Virol; 1996 May; 70(5):3051-9. PubMed ID: 8627783
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of expression of mouse mammary tumor virus through sequences located in the hormone response element: involvement of cell-cell contact and a negative regulatory factor.
    Härtig E; Nierlich B; Mink S; Nebl G; Cato AC
    J Virol; 1993 Feb; 67(2):813-21. PubMed ID: 8380466
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nucleosome-mediated disruption of transcription factor-chromatin initiation complexes at the mouse mammary tumor virus long terminal repeat in vivo.
    Lee HL; Archer TK
    Mol Cell Biol; 1994 Jan; 14(1):32-41. PubMed ID: 8264599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.